| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 4 |
| 1 | NATALIZUMAB | 4 |
| 2 | OCRELIZUMAB | 4 |
| 3 | PREDNISOLONE | 3 |
| 4 | PREDNISOLONE ORAL | 3 |
| 5 | PREDNISOLONE ORAL SOLUTION | 3 |
| 6 | ADALIMUMAB | 2 |
| 7 | AZATHIOPRINE | 2 |
| 8 | DOXORUBICIN | 2 |
| 9 | ESCITALOPRAM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELUMETINIB | 2 | 0.0012 |
| 1 | PIMECROLIMUS | 1 | 0.0006 |
| 2 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| 3 | UBLITUXIMAB | 1 | 0.0003 |
| 4 | ITRACONAZOLE | 2 | 0.0002 |
| 5 | GOLIMUMAB | 2 | 0.0002 |
| 6 | CABOTEGRAVIR AND RILPIVIRINE | 1 | 0.0002 |
| 7 | PEGINTERFERON BETA-1A | 2 | 0.0002 |
| 8 | RILPIVIRINE | 1 | 0.0001 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Integrin Receptor Antagonist [EPC] | 5 | 0.0001 |
| 2 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 7 | 0.0000 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 2 | 0.0000 |
| 8 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |